THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 20 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,294,000 | +112.1% | 1,318,000 | +100.0% | 0.00% | – |
| Q3 2021 | $610,000 | -3.2% | 659,000 | 0.0% | 0.00% | – |
| Q2 2021 | $630,000 | -49.9% | 659,000 | -46.4% | 0.00% | -100.0% |
| Q1 2021 | $1,257,000 | -34.2% | 1,229,000 | -39.0% | 0.00% | 0.0% |
| Q4 2020 | $1,910,000 | +40.1% | 2,016,000 | +33.0% | 0.00% | 0.0% |
| Q3 2020 | $1,363,000 | -75.6% | 1,516,000 | -73.8% | 0.00% | -75.0% |
| Q1 2020 | $5,586,000 | +62.3% | 5,788,000 | +74.0% | 0.00% | +100.0% |
| Q4 2019 | $3,442,000 | +15.5% | 3,326,000 | +3.1% | 0.00% | 0.0% |
| Q3 2019 | $2,979,000 | +27.9% | 3,226,000 | +20.1% | 0.00% | +100.0% |
| Q2 2019 | $2,330,000 | +24.7% | 2,686,000 | +39.2% | 0.00% | 0.0% |
| Q1 2019 | $1,869,000 | – | 1,930,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 25,388 | $23,544,000 | 2.40% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,675,000 | $46,013,000 | 1.22% |
| DeepCurrents Investment Group LLC | 33,824,000 | $31,165,000 | 0.93% |
| Aequim Alternative Investments LP | 13,920,000 | $12,909,000 | 0.50% |
| Maven Securities LTD | 14,280,000 | $14,280,000 | 0.46% |
| Saltoro Capital, LP | 1,350,000 | $1,252,000 | 0.44% |
| Baupost Group | 30,000,000 | $27,640,000 | 0.25% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,182,000 | 0.12% |
| ZAZOVE ASSOCIATES LLC | 1,250,000 | $1,163,000 | 0.10% |
| HBK INVESTMENTS L P | 22,500,000 | $20,832,000 | 0.08% |